U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07845630) titled 'A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body' on Sept. 23.

Brief Summary: The main objective of this trial is to establish the bioequivalence of two different formulations of vicadrostat / empagliflozin in healthy male and female trial participants following oral administration.

Study Start Date: Oct. 14

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Vicadrostat

Vicadrostat

DRUG: Empagliflozin

Empagliflozin

DRUG: Vicadrostat + empagliflozin

Vicadrostat + empagliflozin combined

Recruitment Status: NOT_YET_RECRUITING

S...